| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 1/19/2022 | CLOV Clover Health Investments | Initiated Coverage | $3.00 | $3.00 | Market Perform | High |
| 1/14/2022 | MOLN Molecular Partners | Boost Price Target | $28.00 | $35.00 ➝ $42.00 | Outperform | High |
| 1/13/2022 | FOLD Amicus Therapeutics | Upgrade | $10.00 | $12.00 ➝ $16.00 | Market Perform ➝ Outperform | Low |
| 1/13/2022 | ENTA Enanta Pharmaceuticals | Lower Price Target | $59.00 | $85.00 ➝ $80.00 | Market Perform | High |
| 1/12/2022 | NEO NeoGenomics | Lower Price Target | $23.00 | $50.00 ➝ $45.00 | Outperform | High |
| 1/12/2022 | BPMC Blueprint Medicines | Lower Price Target | $73.00 | $132.00 ➝ $120.00 | Outperform | High |
| 1/11/2022 | ILMN Illumina | Boost Price Target | $384.00 | $420.00 ➝ $430.00 | Market Perform | High |
| 1/10/2022 | KPTI Karyopharm Therapeutics | Boost Price Target | $7.00 | $6.00 ➝ $8.00 | Market Perform | High |
| 1/10/2022 | BEAM Beam Therapeutics | Boost Price Target | $62.00 | $116.00 ➝ $121.00 | Outperform | High |
| 1/7/2022 | ALGS Aligos Therapeutics | Lower Price Target | $3.00 | $29.00 ➝ $15.00 | Outperform | High |
| 1/7/2022 | RCUS Arcus Biosciences | Reiterated Rating | $34.00 | | Outperform | Medium |
| 1/7/2022 | PRTC PureTech Health | Lower Price Target | $38.00 | $76.00 ➝ $70.00 | Outperform | Low |
| 1/7/2022 | THC Tenet Healthcare | Boost Price Target | $77.00 | $78.00 ➝ $88.00 | Market Perform | Medium |
| 1/7/2022 | VCRA Vocera Communications | Upgrade | $79.00 | $36.00 ➝ $79.25 | Underperform ➝ Market Perform | Low |
| 1/7/2022 | UHS Universal Health Services | Boost Price Target | $129.00 | $132.00 ➝ $136.00 | Market Perform | Low |
| 1/6/2022 | CNTB Connect Biopharma | Lower Price Target | $5.00 | $32.00 ➝ $22.00 | Outperform | Low |
| 1/6/2022 | NXGN NextGen Healthcare | Upgrade | $18.00 | $22.00 | Market Perform ➝ Outperform | High |
| 1/6/2022 | PHR Phreesia | Downgrade | $31.00 | $57.00 ➝ $41.00 | Outperform ➝ Market Perform | High |
| 1/6/2022 | VEEV Veeva Systems | Upgrade | $220.00 | $282.00 | Market Perform ➝ Outperform | Low |
| 1/5/2022 | EQ Equillium | Lower Price Target | $4.00 | $18.00 ➝ $14.00 | Outperform | High |
| 1/5/2022 | MYOV Myovant Sciences | Lower Price Target | $14.00 | $23.00 ➝ $21.00 | Market Perform | High |
| 1/4/2022 | AMPS Altus Power | Initiated Coverage | $8.00 | | Buy | Low |
| 1/4/2022 | FDMT 4D Molecular Therapeutics | Initiated Coverage | $16.00 | $30.00 | Outperform | High |
| 12/31/2021 | XERS Xeris Pharmaceuticals | Boost Price Target | $2.00 | $6.00 ➝ $8.00 | Outperform | N/A |
| 12/27/2021 | BBIO BridgeBio Pharma | Lower Price Target | $12.00 | $66.00 ➝ $24.00 | Outperform | N/A |
| 12/23/2021 | BLUE bluebird bio | Reiterated Rating | $8.00 | | Hold | Low |
| 12/23/2021 | ACAD ACADIA Pharmaceuticals | Reiterated Rating | $22.00 | | Buy | Low |
| 12/23/2021 | MRNA Moderna | Reiterated Rating | $174.00 | | Sell | Low |
| 12/22/2021 | ALLK Allakos | Downgrade | $7.00 | $150.00 ➝ $17.00 | Outperform ➝ Market Perform | N/A |
| 12/21/2021 | ALDX Aldeyra Therapeutics | Lower Price Target | $4.00 | $24.00 ➝ $15.00 | Outperform | High |
| 12/21/2021 | GBT Global Blood Therapeutics | Lower Price Target | $28.00 | $56.00 ➝ $53.00 | Outperform | Low |
| 12/20/2021 | APTX Aptinyx | Lower Price Target | $3.00 | $12.00 ➝ $10.00 | Outperform | High |
| 12/20/2021 | GMTX Gemini Therapeutics | Lower Price Target | $2.00 | $25.00 ➝ $15.00 | Outperform | Low |
| 12/20/2021 | CMPX Compass Therapeutics | Initiated Coverage | $3.00 | $12.00 | Outperform | N/A |
| 12/20/2021 | CMPX Compass Therapeutics | Initiated Coverage | $3.00 | $12.00 | Outperform | N/A |
| 12/20/2021 | ACIU AC Immune | Lower Price Target | $5.00 | $17.00 ➝ $15.00 | Outperform | Medium |
| 12/20/2021 | MRNS Marinus Pharmaceuticals | Lower Price Target | $11.00 | $32.00 ➝ $30.00 | Outperform | Low |
| 12/20/2021 | RUBY Rubius Therapeutics | Reiterated Rating | $8.00 | | Hold | High |
| 12/20/2021 | ZGNX Zogenix | Lower Price Target | $26.00 | $37.00 ➝ $32.00 | Outperform | High |
| 12/20/2021 | RLMD Relmada Therapeutics | Lower Price Target | $19.00 | $50.00 ➝ $42.00 | Outperform | High |
| 12/20/2021 | ITCI Intra-Cellular Therapies | Boost Price Target | $39.00 | $45.00 ➝ $50.00 | Outperform | High |
| 12/20/2021 | SAGE Sage Therapeutics | Lower Price Target | $39.00 | $70.00 ➝ $60.00 | Market Perform | Low |
| 12/20/2021 | CERN Cerner | Downgrade | $92.00 | $88.00 ➝ $95.00 | Outperform ➝ Market Perform | Low |
| 12/20/2021 | JAZZ Jazz Pharmaceuticals | Lower Price Target | $141.00 | $230.00 ➝ $200.00 | Outperform | Low |
| 12/20/2021 | BIIB Biogen | Lower Price Target | $231.00 | $450.00 ➝ $325.00 | Outperform | High |
| 12/20/2021 | RGEN Repligen | Reiterated Rating | $190.00 | | Buy | High |
| 12/17/2021 | ALVR AlloVir | Lower Price Target | $9.00 | $37.00 ➝ $32.00 | Outperform | High |
| 12/17/2021 | IONS Ionis Pharmaceuticals | Lower Price Target | $30.00 | $36.00 ➝ $34.00 | Market Perform | High |
| 12/17/2021 | BCYC Bicycle Therapeutics | Initiated Coverage | $47.00 | $70.00 | Outperform | High |
| 12/17/2021 | ZNTL Zentalis Pharmaceuticals | Boost Price Target | $60.00 | $89.00 ➝ $97.00 | Outperform | High |
| 12/16/2021 | XERS Xeris Pharmaceuticals | Reiterated Rating | $2.00 | $6.00 | Buy | Medium |
| 12/16/2021 | HARP Harpoon Therapeutics | Reiterated Rating | $5.00 | | Buy | High |
| 12/16/2021 | AVIR Atea Pharmaceuticals | Reiterated Rating | $7.00 | $11.00 | Hold | High |
| 12/16/2021 | MOLN Molecular Partners | Reiterated Rating | $28.00 | | Buy | High |
| 12/16/2021 | TVTX Travere Therapeutics | Boost Price Target | $26.00 | $37.00 ➝ $42.00 | Outperform | Medium |
| 12/15/2021 | PFE Pfizer | Boost Price Target | $54.00 | $52.00 ➝ $56.00 | Market Perform | High |
| 12/14/2021 | VINC Vincerx Pharma | Reiterated Rating | $7.00 | | Buy | High |
| 12/14/2021 | IMTX Immatics | Boost Price Target | $11.00 | $28.00 ➝ $32.00 | Outperform ➝ Outperform | High |
| 12/14/2021 | GBT Global Blood Therapeutics | Boost Price Target | $28.00 | $54.00 ➝ $56.00 | Outperform | High |
| 12/14/2021 | GILD Gilead Sciences | Reiterated Rating | $69.00 | | Buy | Medium |
| 12/14/2021 | ARNA Arena Pharmaceuticals | Downgrade | $92.00 | $112.00 ➝ $100.00 | Outperform ➝ Market Perform | Medium |
| 12/14/2021 | REGN Regeneron Pharmaceuticals | Reiterated Rating | $618.00 | | Buy | Medium |
| 12/12/2021 | IPHA Innate Pharma | Reiterated Rating | $4.00 | | Buy | High |
| 12/12/2021 | AFMD Affimed | Reiterated Rating | $4.00 | | Buy | High |
| 12/12/2021 | KALV KalVista Pharmaceuticals | Reiterated Rating | $12.00 | $51.00 | Buy | High |
| 12/12/2021 | AZN AstraZeneca | Reiterated Rating | $59.00 | | Buy | Medium |
| 12/12/2021 | ZLAB Zai Lab | Reiterated Rating | $52.00 | | Buy | Medium |
| 12/12/2021 | SNYNF Sanofi | Reiterated Rating | $105.00 | | Buy | High |
| 12/10/2021 | ZYME Zymeworks | Upgrade | $13.00 | | Market Perform ➝ Outperform | Low |
| 12/10/2021 | RNA Avidity Biosciences | Boost Price Target | $15.00 | $36.00 ➝ $53.00 | Outperform | Low |
| 12/10/2021 | PHR Phreesia | Lower Price Target | $31.00 | $75.00 ➝ $57.00 | Outperform | High |
| 12/10/2021 | ZNTL Zentalis Pharmaceuticals | Boost Price Target | $60.00 | $84.00 ➝ $89.00 | Outperform | Low |
| 12/9/2021 | BOLT Bolt Biotherapeutics | Reiterated Rating | $4.00 | | Buy | Medium |
| 12/9/2021 | RDUS Radius Health | Reiterated Rating | $6.00 | $30.00 ➝ $20.00 | Hold | High |
| 12/9/2021 | ACRS Aclaris Therapeutics | Reiterated Rating | $10.00 | $26.00 | Buy | Medium |
| 12/9/2021 | RETA Reata Pharmaceuticals | Reiterated Rating | $28.00 | $282.00 ➝ $35.00 | Outperform ➝ Market Perform | High |
| 12/9/2021 | EW Edwards Lifesciences | Boost Price Target | $116.00 | $130.00 ➝ $135.00 | Outperform | Low |
| 12/8/2021 | RXRX Recursion Pharmaceuticals | Boost Price Target | $12.00 | $30.00 ➝ $32.00 | Outperform | High |
| 12/8/2021 | PRVA Privia Health Group | Boost Price Target | $21.00 | $42.00 ➝ $43.00 | Outperform | High |
| 12/8/2021 | IONS Ionis Pharmaceuticals | Lower Price Target | $30.00 | $39.00 ➝ $36.00 | Market Perform | High |
| 12/8/2021 | RXDX Prometheus Biosciences | Boost Price Target | $34.00 | $43.00 ➝ $47.00 | Outperform | High |
| 12/7/2021 | ABBV AbbVie | Reiterated Rating | $135.00 | | Buy | Low |
| 12/7/2021 | PODD Insulet | Reiterated Rating | $235.00 | | Buy | High |
| 12/5/2021 | ROIV Roivant Sciences | Reiterated Rating | $7.00 | | Buy | N/A |
| 12/5/2021 | ROIV Roivant Sciences | Reiterated Rating | $7.00 | | Buy | N/A |
| 12/3/2021 | UTRS Minerva Surgical | Lower Price Target | $6.00 | $17.00 ➝ $12.00 | Outperform | Low |
| 12/3/2021 | SGRY Surgery Partners | Boost Price Target | $44.00 | $52.00 ➝ $61.00 | Outperform | Medium |
| 12/2/2021 | EQ Equillium | Reiterated Rating | $4.00 | | Outperform | High |
| 12/2/2021 | KDNY Chinook Therapeutics | Reiterated Rating | $14.00 | | Buy | Medium |
| 12/2/2021 | BMRN BioMarin Pharmaceutical | Reiterated Rating | $86.00 | | Buy | Low |
| 12/2/2021 | VEEV Veeva Systems | Lower Price Target | $220.00 | $296.00 ➝ $282.00 | Market Perform | High |
| 12/1/2021 | TALK Italk | Reiterated Rating | $2.00 | | Hold | High |
| 12/1/2021 | ALDX Aldeyra Therapeutics | Reiterated Rating | $4.00 | $24.00 | Buy | High |
| 12/1/2021 | ARNA Arena Pharmaceuticals | Reiterated Rating | $92.00 | | Buy | High |
| 12/1/2021 | ALNY Alnylam Pharmaceuticals | Reiterated Rating | $139.00 | | Hold | Medium |
| 11/30/2021 | ABEO Abeona Therapeutics | Downgrade | $0.00 | $5.00 ➝ $1.00 | Outperform ➝ Market Perform | Medium |
| 11/30/2021 | MRK Merck & Co., Inc. | Reiterated Rating | $81.00 | | Buy | Low |
| 11/25/2021 | DRNA Dicerna Pharmaceuticals | Reiterated Rating | $38.00 | | Buy | Low |
| 11/23/2021 | AMYT Amryt Pharma | Lower Price Target | $10.00 | $23.00 ➝ $19.00 | Outperform | High |
| 11/23/2021 | AIRS Airsculpt Technologies | Initiated Coverage | $14.00 | $26.00 | Outperform | Medium |
